Pearlly S. Yan
0000-0003-1965-4920
Publication & Citation Trends
Publications
0 total
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation OA
Cited by 24
Semantic Scholar
RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension OA
Cited by 18
Semantic Scholar
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia OA
Cited by 24
Semantic Scholar
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity. OA
Cited by 4
Semantic Scholar
Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor–mediated synergistic antileukemic actions OA
Cited by 18
Semantic Scholar
Genome-wide DNA hypermethylation opposes healing in patients with chronic wounds by impairing epithelial-mesenchymal transition OA
Cited by 29
Semantic Scholar
AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells OA
Cited by 18
Semantic Scholar
Research Topics
Epigenetics and DNA Methylation
(113)
RNA modifications and cancer
(49)
Histone Deacetylase Inhibitors Research
(46)
Genomics and Chromatin Dynamics
(38)
Chronic Lymphocytic Leukemia Research
(35)
Affiliations
Marine Mammal Center
University of Bonn
Seoul National University
National Chung Cheng University
Deutz (Germany)